PhRMA

GPTKB entity

Statements (70)
Predicate Object
gptkbp:instanceOf gptkb:professional_association
gptkbp:abbreviation gptkb:PhRMA
gptkbp:CEO gptkb:Stephen_J._Ubl
gptkbp:country gptkb:United_States
gptkbp:focus public policy advocacy
biopharmaceutical research
gptkbp:founded 1958
gptkbp:fullName gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
gptkbp:headquartersLocation gptkb:Washington,_D.C.
https://www.w3.org/2000/01/rdf-schema#label PhRMA
gptkbp:lobbyingExpenditures over $25 million per year (varies by year)
gptkbp:membersInclude gptkb:Boehringer_Ingelheim
gptkb:Jazz_Pharmaceuticals
gptkb:Kyowa_Kirin
gptkb:Bayer
gptkb:Organon
gptkb:Pfizer
gptkb:UCB
gptkb:Sumitomo_Pharma
gptkb:Vertex_Pharmaceuticals
gptkb:Alnylam_Pharmaceuticals
gptkb:Biogen
gptkb:Novo_Nordisk
gptkb:Otsuka_Pharmaceutical
gptkb:Mallinckrodt_Pharmaceuticals
gptkb:BioMarin_Pharmaceutical
gptkb:AstraZeneca
gptkb:Eli_Lilly_and_Company
gptkb:Johnson_&_Johnson
gptkb:Merck_&_Co.
gptkb:Sanofi
gptkb:Incyte
gptkb:LEO_Pharma
gptkb:Endo_International
gptkb:Sunovion_Pharmaceuticals
gptkb:Supernus_Pharmaceuticals
gptkb:Vanda_Pharmaceuticals
gptkb:AbbVie
gptkb:Amgen
gptkb:Genentech
gptkb:Gilead_Sciences
gptkb:Novartis
gptkb:Regeneron_Pharmaceuticals
gptkb:Astellas_Pharma
gptkb:Sage_Therapeutics
gptkb:Takeda_Pharmaceutical_Company
gptkb:Lundbeck
gptkb:Ipsen
gptkb:CSL_Behring
gptkb:Daiichi_Sankyo
gptkb:Servier
gptkb:Alexion_Pharmaceuticals
gptkb:Bristol_Myers_Squibb
gptkb:Vifor_Pharma
gptkb:Eisai
gptkb:Horizon_Therapeutics
gptkb:Sobi
gptkb:United_Therapeutics
gptkb:Travere_Therapeutics
GlaxoSmithKline
gptkbp:notableAction advocacy for drug innovation
lobbying for pharmaceutical industry interests
opposition to drug price controls
support for intellectual property protections
gptkbp:regionServed gptkb:United_States
gptkbp:representsIndustry pharmaceutical industry
gptkbp:taxStatus 501(c)(6) organization
gptkbp:website https://www.phrma.org/
gptkbp:bfsParent gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
gptkbp:bfsLayer 5